KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Dynavax Technologies (DVAX) over the last 7 years, with Dec 2024 value amounting to $0.20.

  • Dynavax Technologies' EPS (Weighted Average and Diluted) rose 75.00% to $0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 380.94%. This contributed to the annual value of $0.20 for FY2024, which is 500.00% up from last year.
  • Per Dynavax Technologies' latest filing, its EPS (Weighted Average and Diluted) stood at $0.20 for FY2024, which was up 500.00% from -$0.05 recorded in FY2023.
  • Dynavax Technologies' 5-year EPS (Weighted Average and Diluted) high stood at $1.97 for FY2022, and its period low was -$0.78 during FY2020.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $0.71, with a median of $0.20 in 2024.
  • As far as peak fluctuations go, Dynavax Technologies' EPS (Weighted Average and Diluted) slumped by 102.54% in 2023, and later spiked by 500.00% in 2024.
  • Yearly analysis of 5 years shows Dynavax Technologies' EPS (Weighted Average and Diluted) stood at -$0.78 in 2020, then soared by 173.08% to $0.57 in 2021, then surged by 245.61% to $1.97 in 2022, then tumbled by 102.54% to -$0.05 in 2023, then skyrocketed by 500.00% to $0.20 in 2024.